
On Oct. 1, Professor and Chief Physician Lars Iversen is joining MC2 Therapeutics as its new chief medical officer.
He comes to the firm from a position at Aarhus University Hospital, where his tasks have included leading a research center for biological and epidemiological studies of psoriasis, atopic dermatitis and skin cancer.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app